-
Clinical Trials Ongoing
Clinical Trials Ongoing
Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.30 | ||
| Change(%) |  | +0.01 | |
| Volume | 829038 | ||
| 8:13 PM - Feb 24, 2010 | |||
News
-
09-10-2009
Enzon to Present at NewsMakers...
Enzon to Present at NewsMakers in the Biotech Industry Conference
-
07-27-2009
Enzon to Release Second Quarte...
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
-
07-27-2009
Enzon to Present at BMO Focus...
Enzon to Present at BMO Focus on Healthcare Conference
-
07-23-2009
Enzon Enhances Governance with...
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director
-
10-30-2007
Enzon Reports Third Quarter 20...
Enzon Reports Third Quarter 2007 Results
-
08-06-2008
Enzon Reports Solid Second Qua...
Enzon Reports Solid Second Quarter 2008 Results
-- Product revenues increase 17% -- -
04-30-2008
Enzon to Release First Quarter...
Enzon to Release First Quarter 2008 Earnings on Wednesday, May 7, 2008; Conference Call and Webcast to Follow
-
12-31-1969
Enzon Pharmaceuticals to Add N...
Enzon Pharmaceuticals to Add New Independent Director to Board
-
11-29-2007
Enzon to Present at BMO Capita...
Enzon to Present at BMO Capital Markets Focus on Healthcare Conference
-
05-22-2008
Enzon Stockholders Approve Com...
Enzon Stockholders Approve Company Proposals at 2008 Annual Meeting
-
09-30-2008
Enzon's New Oncaspar-IV™ Rec...
Enzon's New Oncaspar-IV™ Receives Orphan Drug Status in the EU
-- Improved version to expand global potential -- -
07-23-2009
Enzon Enhances Governance with...
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director